Abingworth LLP
Investor profile
Also recorded as: Abingworth
Deals
6
distinct rounds
Companies
5
backed
Active span
2013–2021
9 yrs
Total round €
€239M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| GenSight Biologics | France | 2 | €65M |
| CRISPR Therapeutics | Switzerland | 1 | €58M |
| Anjarium Biosciences | Switzerland | 1 | €51M |
| Nouscom | Switzerland | 1 | €42M |
| Kesios Therapeutics | UK | 1 | €23M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| CRISPR Therapeutics | Series B | €58M | 2015-03 |
| Anjarium Biosciences | Series A | €51M | 2021-09 |
| Nouscom | Series B | €42M | 2017-11 |
| GenSight Biologics | Series B | €33M | 2015-06 |
| GenSight Biologics | Series A | €32M | 2013-03 |
| Kesios Therapeutics | Series A | €23M | 2015-11 |